NDC Compounded Drug 70092-148-43 Trisodium Citrate Dihydrate
Injection Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Trisodium Citrate Dihydrate
NDC crossover of Sodium Citrate 4% 3 Ml Syr with NDC 70092-148 a human compounded drug with other similar products matching the same substance name (Trisodium Citrate Dihydrate) and the same administration route (intravenous) or dosage form (injection).
| NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
|---|---|---|---|---|---|---|
| 71266-6641-1 | Sodium Citrate | Sodium Citrate | 30 mL in 1 VIAL | Injection | Intravenous | Fagron Compounding Services Llc Dba Fagron Sterile Services Llc Dba Jcb Laboratories |
| 71266-6641-1 | Sodium Citrate | Sodium Citrate | 30 mL in 1 VIAL | Injection | Intravenous | Fagron Compounding Services Llc Dba Fagron Sterile Services Llc Dba Jcb Laboratories |
| 71266-6641-1 | Sodium Citrate | Sodium Citrate | 30 mL in 1 VIAL | Injection | Intravenous | Fagron Compounding Services Llc Dba Fagron Sterile Services Llc Dba Jcb Laboratories |
| 71266-6641-1 | Sodium Citrate | Sodium Citrate | 30 mL in 1 VIAL | Injection | Intravenous | Fagron Compounding Services Llc Dba Fagron Sterile Services Llc Dba Jcb Laboratories |
Frequently Asked Questions
What is the NDC number assigned to Sodium Citrate?
Sodium Citrate was assigned by its manufacturer with NDC product code 70092-148. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Sodium Citrate?
The NDC package code 70092-148-43 was assigned to a 3 mL in 1 SYRINGE of trisodium citrate dihydrate administered intravenous via injection.
Who manufactures this product?
Sodium Citrate is manufactured by an outsourced facility and labeled by Quva Pharma, Inc.. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 4 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories with NDC product codes 71266-6641-1, 71266-6641-1, 71266-6641-1 and 71266-6641-1.